The author focuses on the revised Heart Failure Society of America's (HFSA) 2010 Guidelines, which reflects the observation that patients with a wide left bundle branch block and a wide QRS duration are most likely to benefit from cardiac ...
MIRACLE (Multicenter InSync Randomized Clinical Evaluation) trialVENTAK‐CHF/CONTAK‐CD studyCOMPANION trialRD‐CHF (Right/Dual‐CHF) TrialCARE‐HF (Cardiac Resynchronization–Heart Failure) trialThis chapter contains sections titleddoi:10.1002/9781444300246.ch14David L. Hayes MD Chair...
These Boston Scientific Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharmacologic therapy (OPT) for heart failure and who meet any one of the following classifications: Moderate to severe heart failure (NYHA Class III...
cardiac resynchronization therapy (CRT) ‐ indications for treatment and strategies for optimizing resultsCRT, one of the most powerful modalities ‐ to treat patients with systolic heart failureCRT, treating dys‐synchrony using biventricular (BV) pacing ‐ to resynchronize left and right ventricular ...
Implantable cardioverter-defibrillator (ICDs), cardiac resynchronization (CRT) and combination (CRT-D) therapy have become an integral part of the management of patients with heart failure with reduced ejection fraction (HFrEF). ICDs treat ventricular arrhythmia and CRTs improve left ventricular systolic...
therapy medically necessary for an indication outlined in Section I when the member has demonstrated a positive clinical response to therapy (e.g., improvement or maintenance in best corrected visual acuity [BCVA] or visual field, or a reduction in the rate of vision decline or the risk of mo...
It says that randomized clinical trials were performed in patients with heart failure to compare the effect of the combined process with the use of ICD therapy alone. It reveals that CRT-ICD showed consistency on reducing heart failure and electrocardiographic dyssynchrony....
Johannes Holzmeister, William T. Abraham. (2010) Device therapy: Indications for ICD–CRT in mildly symptomatic heart failure. Nature Reviews Cardiology 7 , 7-8 /Holzmeister J,Abraham WT.Device therapy:Indications for ICD-CRT in mildly symptomatic heart failure.Nat Rev Cardiol. 2010...
Cardiac resynchronisation therapy (CRT) was first introduced for clinical use in 1996 and has been approved for treatment of heart failure (HF) and incorporated into guidelines for almost a decade. However, the question of deciding who will benefit most from this treatment remains open and ...
MIRACLE (Multicenter InSync Randomized Clinical Evaluation) trialVENTAK-CHF/CONTAK-CD studyCOMPANION trialRD-CHF (Right/Dual-CHF) TrialCARE-HF (Cardiac Resynchronization–Heart Failure) trialdoi:10.1002/9781444300246.CH14D. HayesW. AbrahamJohn Wiley & Sons, Ltd...